𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bayes factors for genome-wide association studies: comparison with P-values

✍ Scribed by Jon Wakefield


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
172 KB
Volume
33
Category
Article
ISSN
0741-0395

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The Bayes factor is a summary measure that provides an alternative to the P‐value for the ranking of associations, or the flagging of associations as “significant”. We describe an approximate Bayes factor that is straightforward to use and is appropriate when sample sizes are large. We consider various choices of the prior on the effect size, including those that allow effect size to vary with the minor allele frequency (MAF) of the marker. An important contribution is the description of a specific prior that gives identical rankings between Bayes factors and P‐values, providing a link between the two approaches, and allowing the implications of the use of P‐values to be more easily understood. As a summary measure of noteworthiness P‐values are difficult to calibrate since their interpretation depends on MAF and, crucially, on sample size. A consequence is that a consistent decision‐making procedure using P‐values requires a threshold for significance that reduces with sample size, contrary to common practice. Genet. Epidemiol. 2008. © 2008 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


P-value based analysis for shared contro
✍ Dmitri V. Zaykin; Damian O. Kozbur 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 2 views

## Abstract An appealing genome‐wide association study design compares one large control group against several disease samples. A pioneering study by the Wellcome Trust Case Control Consortium that employed such a design has identified multiple susceptibility regions, many of which have been indepe

A comparison of strategies for analyzing
✍ Ming-Huei Chen; Xuan Liu; Fengrong Wei; Martin G. Larson; Caroline S. Fox; Ramac 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 1 views

Genome-wide association studies (GWAS) have been frequently conducted on general or isolated populations with related individuals. However, there is a lack of consensus on which strategy is most appropriate for analyzing dichotomous phenotypes in general pedigrees. Using simulation studies, we compa

Quality control and quality assurance in
✍ Cathy C. Laurie; Kimberly F. Doheny; Daniel B. Mirel; Elizabeth W. Pugh; Laura J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB

## Abstract Genome‐wide scans of nucleotide variation in human subjects are providing an increasing number of replicated associations with complex disease traits. Most of the variants detected have small effects and, collectively, they account for a small fraction of the total genetic variance. Ver

Stratified false discovery control for l
✍ Lei Sun; Radu V. Craiu; Andrew D. Paterson; Shelley B. Bull 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

## Abstract The multiplicity problem has become increasingly important in genetic studies as the capacity for high‐throughput genotyping has increased. The control of False Discovery Rate (FDR) (Benjamini and Hochberg. [1995] J. R. Stat. Soc. Ser. B 57:289–300) has been adopted to address the probl

Using the gene ontology to scan multilev
✍ Daniel J. Schaid; Jason P. Sinnwell; Gregory D. Jenkins; Shannon K. McDonnell; J 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 1 views

## Abstract Gene‐set analyses have been widely used in gene expression studies, and some of the developed methods have been extended to genome wide association studies (GWAS). Yet, complications due to linkage disequilibrium (LD) among single nucleotide polymorphisms (SNPs), and variable numbers of

Genome-wide association study of genetic
✍ Darren Plant; John Bowes; Catherine Potter; Kimme L. Hyrich; Ann W. Morgan; Anth 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## Objective Anti–tumor necrosis factor (anti-TNF) agents are successful therapies in rheumatoid arthritis (RA); however, inadequate response occurs in 30–40% of patients treated. Knowledge of the genetic factors that influence response may facilitate personalized therapy. The purpose of this study